Ligand Pharmaceuticals Inc (NASDAQ:LGND)

195.97
Delayed Data
As of 3:56pm ET
 +2.48 / +1.28%
Today’s Change
114.79
Today|||52-Week Range
201.30
+43.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues64.5M71.9M109.0M141.1M
 
 
 
 
 
Cost of Goods Sold6.5M3.2M4.9M5.0M
 
 
 
 
 
Depreciation And Amortization2.7M2.6M11.3M12.5M
 
 
 
 
 
 
Operating ExpensesGross Income55.4M66.1M92.8M123.6M
 
 
 
 
 
General Expenses34.7M37.8M47.8M55.5M
 
 
 
 
 
Research And Development12.1M13.4M21.2M26.9M
 
 
 
 
 
Total Operating Expenses43.8M43.6M64.1M73.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income20.7M28.3M44.9M68.1M
 
 
 
 
 
Extraordinary Credit544.0K27.2M300.0K3.2M
 
 
 
 
 
Extraordinary Charge-6.8M-5.8M-4.4M-2.6M
 
 
 
 
 
Pre-Tax Equity Earnings---5.1M-23.1M-2.0M
 
 
 
 
Interest Expense On Debt4.9M11.8M12.2M11.4M
 
 
 
 
 
Other Expenses1.7M2.5M2.4M2.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income11.3M35.3M8.0M57.2M
 
 
 
 
 
Income Taxes-410.0K-192.1M-10.3M-44.7M
 
 
 
 
 
Minority Interest-1.1M-2.4M0.000.00
 
 
 
Extraordinary Items0.000.00731.0K0.00
 
 
Net Income12.0M229.8M-2.4M12.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS20.4M19.8M20.8M21.0M
 
 
 
 
 
Shares To Calculate EPS Diluted21.4M21.2M20.8M23.5M
 
 
 
 
 
 
Earnings Per ShareEPS$0.56$10.83-$0.08$0.53
 
 
 
 
 
EPS Diluted$0.56$10.83-$0.11$0.53